Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...
Hosted on MSN17d
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
Advanced Micro Devices is investing $20 million in Absci, a drug-discovery company based in Washington state, in a move aimed at selling its artificial intelligence chips in the healthcare ...
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...
Absci shares jump as analyst lauds 'practical' AI drug company
"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...
Absci Looks Cheap And Positioned For Growth With AMD's AI Backing
Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...
AbSci’s Strategic Partnerships and Strong Financial Position Justify Buy Rating
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on AbSci (ABSI – Research Report). The associated price ...
Benzinga.com17d
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AMD collaborates with Absci for AI drug discovery advancements. AMD makes a $20 million investment to boost drug research. The partnership will leverage AMD Instinct accelerators and ROCm ...
GEN15d
StockWatch: Will Expanding to Life Sciences Reverse AMD’s Stock Decline?
Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that ...